PDCD1 and melanoma: In an analysis of fecal microbiome samples of melanoma patients undergoing anti-PD-1 immunotherapy, diversity and composition of gut microbiome of responders showed significantly higher alpha diversity and relative abundance of bacteria of Ruminococcaceae family compared to nonresponders (99).